Though UK-based pharmaceutical company Compass Pathways reached its primary endpoint from its June 23 Phase 3 trial to use synthetic psilocybin for treatment-resistant depression (TRD), investors were seemingly underwhelmed. That same day, shares plunged 46% to a record low of $2.35 a share for the biotech firm. But Kabir Nath, CEO of Compass, defends the […]
Tag Archives: psychedelic therapy depression
Dr. Cameron Lacey has spent years studying how psychedelics might help treat depression and other mood disorders. Last week, he became the first and only psychiatrist in New Zealand allowed to prescribe psilocybin, the hallucinogenic found in āmagic mushrooms.ā The approval from New Zealandās health ministry is the latest boost to a growing global movement […]